Network Health Dietitians July 08 Issue 36

short bowel syndrome
of her small bowel after surgery most of the children gained weight SIBO Small intestinal bowel over-
due to necrotizing enterocolitis faster. More recently Uchida et al growth
(2). Repeated infections occurred, reported a trial with the same prod-
particularly with the yeast Candida uct in four SBS children matched
TPN Total parenteral nutrition
albicans, due to her central venous with four healthy controls (18). After
References
catheter and increased bowel per- nine months, a signiﬁ cant increase 1. American Gastroenterology Association (2003)
meability. Ranitidine (an H2-receptor in serum lymphocyte counts and
American Gastroenterology Association medical
antagonist) was discontinued and a concentrations of pre-albumin was
position statement: short bowel syndrome and
intestinal transplantation. Gastroenterol 124,
probiotic administered enterally (L. observed, as well as faster growth
1105-1110.
casei Shirota at 6.5 x 109 per day) (height and weight gain) and im- 2. Bongaerts G et al (2006) Lacobacillus fermen-
but after her blood pH dropped, proved faecal ﬂ ora.
tum bacteremia in a seriously ill premature small
the dosage was reduced to 8 x
bowel patient during probiotic Lactobacillus
casei therapy. Int J Probiotics & Prebiotics 1(2),
108 per day. After three days, the Conclusions
145-148.
yeast was no longer detected in the As no large scale, placebo con- 3. Candy DCA et al (2001) Effect of administra-
faeces. When the patient needed a trolled trials have been conducted,
tion of Lactobacillus casei Shirota on sodium
course of antibiotics, treatment was one cannot conclude that probiot-
balance in an infant with short bowel syndrome.
J Pediatr Gastroenterol Nutr 32, 502-508.
switched to a multi-strain probiotic ics and/or prebiotics are proven to
4. Dibaise JK et al (2006) Enteric microﬂ ora,
to increase the chances of probiotic be of beneﬁ t for SBS and SIBO. How-
bacterial overgrowth, and short-bowel syndrome.
survival (a mixture of Biﬁ dobacterium ever, the evidence from small studies
Clin Gastroenterol Hepatol 4, 11-20.
biﬁ dum, B. infantis¸ B. longum, L. aci- or case reports with certain probiotic
5. Gaon D et al (2002) Effect of Lactobacillus
strains (L. casei and L. acidophilus strains CERELA)
dophilus, L. casei and Lactococcus strains and synbiotic preparations is on bacterial overgrowth-related chronic diar-
lactis at a dose of 109 CFU per day). mostly positive. Patients should be
rhoea. Medicina Buenos Aires 62, 159-163.
Lactobacillus was subsequently iso- closely monitored for development
6. Gibson GR & Roberfriod MB (1995) Dietary
modulation of the human colonic microbiota
lated from blood culture but proved of sepsis and acidosis.
introducing the concept of prebiotics. J Nutr 125,
not to be any of the probiotic strains. 1401-1412.
Restoring normal gastric acid secre- Acknowledgements
7. Kanamori Y et al (2001) Combination therapy
tion (by stopping the ranitidine) was We thank Professor David Candy
with Biﬁ dobacterium breve, Lactobacillus casei,
and galactooligosaccharides dramatically
highlighted as being most important (Royal West Sussex NHS Trust) for
improved the intestinal function in a girl with short
in creating the right conditions for his advice during the writing of this bowel syndrome. Digestive Dis Sci 9, 2010-2016
development of a normal com- article.
8. Kanamori Y et al (2004) Experience of long-
mensal microbiota. The patient was
term synbiotic therapy in seven short bowel
patients with refractory enterocolitis. J Pediatr
still on full enteral feed at the age of Glossary & abbreviations
Surg 39, 1686-1692.
three years, with adequate growth Crohn’s disease - a condition in
9. Ku WH et al (2006) Probiotics provoked D-lac-
and normal mental development. which segments of the alimentary
tic acidosis in short bowel syndrome: case report
and literature review. J Paediatr 11, 246-254.
canal become inﬂ amed, thickened
10. Kunz AN et al (2004) Two cases of Lactoba-
Synbiotic studies and ulcerated. cillus bacteremia during probiotic treatment
Three papers described use of a
of short gut syndrome. J Pediatr Gastro Nutr 38,
new synbiotic preparation contain-
Necrotizing enterocolitis - a serious
457-458.
11. Lennard-Jones JE (1990) Indications and need
ing two probiotics (B. breve Yakult,
disease affecting the bowel in the
for long-term parenteral nutrition: implications for
L. casei Shirota) and a prebiotic ga-
ﬁ rst three years of life, more common
intestinal transplantation. Transplant Proc, 22(6),
lactooligosaccharide. The ﬁ rst case
in preterm babies. This is a common
2427-9.
study described a young girl left with
cause of SBS. 12. Nicholson, JK et al (2005) Gut microorgan-
isms, mammalian metabolism and personalised
only 25 cm of small intestine follow- Probiotics are live microorganisms,
healthcare. Nature Reviews Microbiology 3,
ing surgery (7). SIBO was diagnosed: which when administered in ade- 431-438.
she was not growing properly and quate doses confer a health beneﬁ t
13. Nightingale J & Woodward JM (2006) Guide-
suffering repeated episodes of fever on the host (20).
lines for management of patients with a short
bowel. Gut 55 (Suppl IV). iv1-iv12.
and acidosis. Her central venous
catheter was discontinued and the
Prebiotics are non-digestible food
14. Quigley E & Quera R (2006) Small Intestinal
Overgrowth: Roles of Antibiotics, Prebiotics, and
synbiotic administered orally. Fae-
ingredients that selectively stimulate
Probiotics. Gastroenterol 130, s78-s90.
cal analysis detected the probiotic
the growth and/or activity of one 15. Schalamon J et al (2003) Mortality and
strains after one month, and an
or a limited number of bacteria in
economics in short bowel syndrome. Best Prac-
improved gut ﬂ ora showing a drop in
the colon that have the potential to
tice Research Clinical Gastroenterology 17(6),
931-942.
E. coli and Candida counts. Lactate
improve health (6)
16. Sentongo TA et al (2008) Intestinal perme-
ability and effects of Lactobacillus rhamnosus
remained at high levels in the faeces Steatorrhoea is the passage of
therapy in children with short bowel syndrome. J
but no further episodes of severe abnormally increased levels of fat in Pediatr Gastroenterol Nutr 46, 41-47.
acidosis occurred, which the authors the faeces (>5 g/day). The faeces
17. Stotzer PO et al (1996) Probiotic treatment of
attributed to a switch from produc- are pale, have an offensive smell,
small intestinal bacterial overgrowth by Lacto-
bacillus fermentum KLD. Scand J Infect Dis 28,
tion of D-lactate to L-lactate. The may look greasy and are difﬁ cult to
615-619.
patient generally showed improved ﬂ ush away. 18. Uchida K et al (2007) Immunonutritional
intestinal function and motility there-
effects during synbiotics therapy in pediatric
after.
Synbiotics are products that contain patients with short bowel syndrome. Pediatr Surg
A long term study examined the
a combination of probiotic and pre-
Int 23, 243-248.
same synbiotic with seven SBS chil-
biotic. The theory is the prebiotic will
19. Vanderhoof JA et al (1998) Treatment strate-
gies for small bowel bacterial overgrowth in short
dren (8). After one year there was
favour the growth of the probiotic
bowel syndrome. J Pediatr Gastroenterol Nutr 27,
improved intestinal microbiota and
organism in the gut. 155-160.
20. WHO/FAO Joint Working Group (2002) Guide-
levels of short chain fatty acids, and SBS Short bowel syndrome lines for the evaluation of probiotics in food.
24 NHDmag.com July ‘08 - issue 36
Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 | Page 17 | Page 18 | Page 19 | Page 20 | Page 21 | Page 22 | Page 23 | Page 24 | Page 25 | Page 26 | Page 27 | Page 28 | Page 29 | Page 30 | Page 31 | Page 32 | Page 33 | Page 34 | Page 35 | Page 36